This is the authors' abstract. We don't add key points for this paper.
The La nucleoprotein/Sjögren syndrome type B antigen (La/SSB) is an RNA-binding factor in the nucleus that is associated with autoimmune diseases. In this study, we show that La/SSB is a biomarker for liver cancer. We detected full-length La/SSB in several liver cancer cell lines, but not in colorectal cancer cell lines. Importantly, serological analysis using a hepatocellular carcinoma (HCC) mouse model and human samples demonstrated that extracellular detection of La/SSB is specific for HCC. Furthermore, we found that the addition of exogenous La/SSB extract induces extracellular signal-regulated kinase (ERK) activation, which leads to accelerated cell growth. This study suggests that the La/SSB is a novel biomarker for HCC, and in the microenvironment, it may act as a growth factor in the progression of liver cancer.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mochimaru et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: